May 17, 2025 08:05 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre picks Shashi Tharoor to head all-party delegation for 'exposing' Pak-backed terrorism globally | Rape convict, survivor express willingness to get married; exchange flowers in Supreme Court | 'Are nukes safe with irresponsible and rogue nation like Pakistan?': Rajnath Singh questions world | 'Go and apologise': Supreme Court slams Madhya Pradesh minister over remark against Colonel Sofiya Qureshi | 'Can timelines be imposed?': President Murmu's question to Supreme Court on Tamil Nadu verdict | 'Had Indira Gandhi been alive, I would've asked her why PoK was not taken back in Simla Agreement': Himanta Biswa Sarma | India's stand demanding vacation of Pak-occupied Kashmir unchanged: MEA | PM Modi visits Adampur Air Base days after Operation Sindoor | Jammu and Kashmir: Three Lashkar-e-Taiba terrorists killed in encounter with security forces in Shopian | US: Two Indian students die in road mishap in Pennsylvania
Sinopharm
Image Credit: wikipedia.org

China's Sinopharm Covid-19 vaccine gets WHO's nod for emergency use

| @indiablooms | May 08, 2021, at 04:50 am

Geneva/IBNS: The World Health Organisation (WHO) on Friday gave emergency use approval for a coronavirus vaccine made by China's state-owned drug manufacturer Sinopharm, said a Reuters report.

The vaccine is one of the two shots made by China and has been exported to several countries and given to millions of people in China, according to the report.

It is also the first vaccine made by a non-western country to get the UN health body's approval and also the first Chinese vaccine to get its nod for any infectious disease, the report said.

This draws significance as WHO's approval is a benchmark of safety and efficacy of a product for countries. It also means that the Chinese vaccine can now be included in COVAX, the programme to make available coronavirus vaccine to poor countries across the globe.

Johnson & Johnson, AsyraZeneca, Pfizer-BioNTech and Moderna have so far received approval for emergency use from WHO.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu